Innovation is central to our approach, driving us to develop groundbreaking solutions across all functions to enhance patient care. Our integration of pharmaceuticals and diagnostics uniquely positions us to make significant impacts along the patient journey. We’re committed to transforming innovative ideas into life-changing solutions for a global community, investing in research and partnerships to achieve this.
This year, we’ve strengthened our environmental stewardship, focusing on sustainable service to our stakeholders for the long term. With a forward-looking mindset, we are dedicated to creating a healthier future for people and the planet.
“We are convinced that our strategy, which is focused on innovation in pharmaceuticals and diagnostics, ensures we remain in a strong position.”
Dr Severin Schwan
Chairman
“2023 was both a demanding and a successful year for Roche – with strong business performance, promising medical advances and key partnerships and acquisitions.”
Dr Thomas Schinecker
CEO Roche Group
Discover how Roche made an impact in 2023
Discover our innovative journey in revolutionising patient care and how we’ve impacted millions worldwide. Explore our Annual Report to see our strides in pharmaceuticals and diagnostics.
At the core of our mission lies a spirit of innovation. We constantly challenge norms to revolutionize our approach to serving patients. With our unique capabilities across the pharmaceuticals and diagnostics divisions, we aim to elevate patient care at each step of the patient journey. Our commitment? To turn groundbreaking ideas into real-world health solutions through advanced research and strategic partnerships. Our approach is global, aiming to impact lives across all communities. In 2023, our pharmaceuticals division generated impressive sales growth thanks to our newer medicines. We are excited about the progress in our product pipeline, notably in oncology, ophthalmology, and neuroscience. With strong base business growth in our diagnostics division, we have introduced pioneering assays, including the world's first immunoassay to diagnose sepsis in newborns, and innovative Alzheimer's disease assays. Additionally, we have forged important partnerships in areas of high unmet need. This year, we've strengthened our commitment to environmental sustainability, focusing on immediate needs while also strategically planning for long-term sustainable care. With a focus on evolving patient needs, we're committed to creating a healthier, more sustainable future for people and our planet.
Key highlights2023
Roche Group sales:
CHF 58.7 billion
Pharmaceuticals Division sales:
CHF 44.6 billion
Diagnostics Division sales:
CHF 14.1 billion
Core investments in
research and development:
CHF 13.2 billion
Core operating profit:
CHF 19.2 billion
Dividend proposal:
CHF 9.60
*Unless otherwise stated, all growth rates and comparisons to the previous year are at constant exchange rates (CER; average rates 2022) and all total figures quoted are reported in CHF.
Polivy
Columvi
Vabysmo
Xofluza
Hemlibra
Ronapreve
Columvi
Evrysdi
Polivy (two indications)
Xofluza
Evrysdi
Vabysmo
Columvi
Phesgo
Phesgo
Actemra/RoActemra
MabThera/Rituxan
(two indications)
1 new platform
4 new tests
2 other
9 new tests
1 new digital solution
5 new platforms
8 new tests
3 new digital solutions
3 new digital solutions
were treated with Roche medicines in 2023,
compared to 33 LLMICs in 2021.
were tested with Roche’s HPV high-risk testing in 2023 – more than 600,000 of these women in low- and middle-income countries.
in Pakistan was launched in partnership with Greenstar Social Marketing (Guarantee) Limited in 2023 to improve diabetes management for women, with the goal to reach over one million individuals in the next three years.
We continue to work with City Cancer Challenge, who are now active in 14 cities worldwide reaching an estimated
66.5 million people.
in scope of our LLMICs access goal used our core medicines in 2023, as we aim to double access from 27,000 patients between 2021 and 2026.**
in 29 countries have been reached through the Changing Diabetes in Children programme, a partnership with Novo Nordisk, since its launch in 2009.
in Africa were trained through the Global Access Program to address critical shortages of lab technicians and support the need for more quality diagnostic services.
were approved or approval was in progress in LLMICs, compared to 60% in 2021.
were delivered to customers worldwide in 2023.
*Low-lower-middle-income countries (LLMICs)
**2023 saw a decline in the use of Actemra/RoActemra for COVID-19; however this was compensated by increases in other medicines.
women in executive positions
under-represented nationalities in executive positions*
new diversity networks or chapters formed in 2023, bringing the total to 127
global DE&I strategy focuses on four pillars: patient, people, culture and society
in pay between men and women in similar jobs as our organisation-wide analysis confirmed
Caroline Creven Fourrier joins Roche as Chief Diversity Officer
*Includes individuals from countries in Asia, Latin America, Eastern Europe, Middle East and Africa.
Commitment to environmental sustainability
Roche’s progressive approach to environmental protection and management reflects our strong commitment to risk mitigation and is intrinsic to our business.
We measure our impact on the environment using the eco-balance metric and strive to continuously lower it by consuming less energy, reducing emissions to air, using less water, and producing less general and chemical waste.
Antoine helps us improve care for people with MS
Antoine is passionate about helping people better understand multiple sclerosis (MS), a neurological disease affecting 2.9 million people. As a Roche patient expert, he regularly shares details about his life with MS to help us improve our delivery of care for people with MS. His resilience and positivity in the face of setbacks associated with MS are an inspiration for us all – reminding us to prioritise what truly matters in life.
“Living with MS provides a new perspective – I no longer worry about trivial matters. It alters your mindset and behaviour, and I believe it has improved my outlook on life.”
Women’s health achievements
Historically, healthcare has often overlooked women’s unique needs, leading to disparities in research, treatment and access. Roche’s #MyStoryForChange launched in 2023, addresses this by empowering women to share their health stories. The campaign has collected over 630 stories, transforming them into powerful agents of change. These stories illustrate the pressing need for a healthcare system that equitably understands and caters to women’s specific needs.
Freedom to Be
Let’s put health equity at the forefront because every woman, everywhere deserves quality healthcare. By giving women the Freedom to Be, we can change the facts to do better for ourselves, our loved ones and future generations.
[Text on video] We ran a social experiment with women to see if they recognised the realities that affect their health. This is what they discovered.
[Woman]
Hi, are you ready?
Yes
[Woman]
In a day, men speak about 7000 words while women speak about 20000 words
[Woman]
no no
[Woman]
agree
[Woman]
Women spend nearly one year of their lives deciding what to wear. Oh yeah probably so.
[Woman]
Women have avoided or delayed seeking medical care because of family obligation. For sure, yeah thank you yeah.
[Text on video] 1 in 5 women shoulder the majority of caregiving responsibilities at home.
[Woman]
More than 90% of women make decisions related to their family's health. Being a single mother of a seven-year-old son, I am the only one who is the sole caregiver of my son.
[Woman]
That's really very sad because I understand that women always put their loved ones first before they put themselves.
[Woman]
Women still face pressure to conform. Definitely it starts from the family.
[Text on video] 1 in 2 women feel pressured to get married at the right age.
[Woman]
In 75 of cases diseases that affect primarily women are underfunded compared to diseases that affect primarily men. Oh this this is really sad.
[Woman]
It's underfunded and it's more than half as well.
[Woman]
Yeah these facts are uncomfortable for me to read but that's the reality.
[Woman]
I'm actually quite stressed reading the facts about women I really think that women need to be really treated fairly
[Man]
I didn't realize they were quite so disparative that there was such a big gap in some of them
[Woman]
There were some facts okay that were presented that I was pretty shocked about
[Woman]
I think women know I think everyone need to actually come together and let women's voices be heard
[Woman]
so I'm very glad I brought my parents here today because although I'm very blessed and privileged to have such a supportive family I think looking at all those statistics really allows them to be more understanding about what's happening with women today
[Woman]
These Healthcare realities are facts but we don't have to live with them. Women and everyone around us can help to change the facts
[Man]
We need to make a change we need to change the facts and we need to start as soon as possible like now thank you
[Text on video]
72% of respondentss said there was stigma attached to women who face difficulty conceiving children.
1 in 5 women have delayed or avoided medical treatment due to a family obligation.
1 in 3 women have given up their career due to expectations of family, friends, and the community.
By giving women the freedom to be, we can change the facts to do better
A future free from cervical cancer
Travel from Ceredigion, Wales, to Comunidad El Salvador in the heart of the Peruvian Amazon to learn more about how HPV self-collection is empowering women to protect themselves against cervical cancer.
This video was produced for Roche by @BBC StoryWorks.
[00:13]
el cáncer de cuello uterino es un problema de salud pública mundial en el mundo entero muchas mujeres mueren por cáncer de cuello uterino por ello requiere nuestra atención inmediata cada día mueren seis mujeres por cáncer de cuello uterino en el Perú trabajo en la dirección de
[00:37]
prevención y control del cáncer del Ministerio de salud la principal motivación que yo tuve para elegir ayudar otras personas en prevención de cáncer fue que alguien muy cercano a mí tuvo esta enfermedad Y lamentablemente la enfermedad ganó y esta persona fue mi mamá
[01:04]
That's your mummy and John Oh Look at this One I have Always been inspired by the incredible women In my life you all TR to Catch the Pet l they encouraged me to go And Live my Dream to go out there and really help people there was six the one Yeah yeah yeah Buenos días Este doctores colegas
[01:47]
compañeros todos mañana tenemos la intervención en la comunidad del Salvador contra el bph pues al explicarles que ese examen nuevo que se está implementando eh se hace con un isopo y ya no requieren el uso del espéculo Y si la mujer no acude a un chequeo preventivo de manera oportuna va
[02:22]
a tener en algunos años una lesión precancer gena que si no lleva un tratamiento va terminar unc cal Cancer is lar preventable unfortunately not everyone has a cervical screen done in the UK for example one in three individuals don't go For screening barriers To cical screening
[02:54]
can be physical psychological societal and cultural and and infor aquí en la amazonía las dificultades son aún mayores Por lo cual las mujeres tienen que madrugar para tomar bote para que les permita llegar al centro de para su atención médica otra de las barreras podría ser el
[03:34]
machismo porque muchas veces las mujeres tienen que pedirle permiso a su pareja para que tomen la decisión de acudir a un establecimiento a buscar una atención médica También tienen que dejar a sus hijos menores de edad solos en casa y faltar incluso al trabajo ese día para
[03:51]
poder ir a su control preventivo de cáncer voy a abrir el isopo Ahí está ya tres vueltas como que estuviéramos moviendo Una cucharita en una taza y este examen lo puede hacer uno mismo lo que se va a realizar hoy día se llama el examen de autotoma para detección del papiloma virus a me parece
[05:01]
han trao este equipo del centro de salud porque no hay tiempo irnos a un examen paraa healg goals to eliminate cal Cancer with Big strides by the year 2030 And I believe that self sampling is amaz yo tengo fe que algún día el cáncer de cuello de útero pasará la historia creo
[05:37]
que es la primera vez que vienen a hacer una campaña grande acá en la comunidad verdad no va a ser la última